- Company Overview for ROQUEFORT THERAPEUTICS PLC (12819145)
- Filing history for ROQUEFORT THERAPEUTICS PLC (12819145)
- People for ROQUEFORT THERAPEUTICS PLC (12819145)
- More for ROQUEFORT THERAPEUTICS PLC (12819145)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Aug 2021 | SH01 |
Statement of capital following an allotment of shares on 18 August 2021
|
|
19 May 2021 | SH01 |
Statement of capital following an allotment of shares on 7 May 2021
|
|
19 May 2021 | SH01 |
Statement of capital following an allotment of shares on 22 March 2021
|
|
17 May 2021 | PSC08 | Notification of a person with significant control statement | |
17 May 2021 | AP01 | Appointment of Dr Michael Lewis Stein as a director on 22 March 2021 | |
17 May 2021 | PSC07 | Cessation of Glenn Ross Whiddon as a person with significant control on 22 March 2021 | |
17 May 2021 | PSC07 | Cessation of Stephen Paul West as a person with significant control on 22 March 2021 | |
12 Jan 2021 | AD01 | Registered office address changed from 3 Bettridge Road London SW6 3QB United Kingdom to Eccleston Yards 25 Eccleston Place London SW1W 9NF on 12 January 2021 | |
26 Nov 2020 | SH01 |
Statement of capital following an allotment of shares on 20 November 2020
|
|
25 Nov 2020 | CERT8A | Commence business and borrow | |
25 Nov 2020 | SH50 | Trading certificate for a public company | |
20 Nov 2020 | MA | Memorandum and Articles of Association | |
20 Nov 2020 | RESOLUTIONS |
Resolutions
|
|
09 Nov 2020 | AP01 | Appointment of Mr Mark Andrew Rollins as a director on 2 November 2020 | |
17 Aug 2020 | AA01 | Current accounting period extended from 31 August 2021 to 31 December 2021 | |
17 Aug 2020 | NEWINC |
Incorporation
Statement of capital on 2020-08-17
|